List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psoriasis Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Psoriasis Treatment Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 TNF Inhibitors
1.4.3 Phosphodiesterase Inhibitors
1.4.4 Interleukin Blockers
1.5 Market by Application
1.5.1 Global Psoriasis Treatment Market Share by Application: 2022-2027
1.5.2 Oral
1.5.3 Injectable
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Psoriasis Treatment Market
1.8.1 Global Psoriasis Treatment Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Psoriasis Treatment Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Psoriasis Treatment Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Psoriasis Treatment Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Psoriasis Treatment Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Psoriasis Treatment Sales Volume Market Share by Region (2016-2021)
3.2 Global Psoriasis Treatment Sales Revenue Market Share by Region (2016-2021)
3.3 North America Psoriasis Treatment Sales Volume
3.3.1 North America Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.3.2 North America Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Psoriasis Treatment Sales Volume
3.4.1 East Asia Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Psoriasis Treatment Sales Volume (2016-2021)
3.5.1 Europe Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Psoriasis Treatment Sales Volume (2016-2021)
3.6.1 South Asia Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Psoriasis Treatment Sales Volume (2016-2021)
3.7.1 Southeast Asia Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Psoriasis Treatment Sales Volume (2016-2021)
3.8.1 Middle East Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Psoriasis Treatment Sales Volume (2016-2021)
3.9.1 Africa Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Psoriasis Treatment Sales Volume (2016-2021)
3.10.1 Oceania Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Psoriasis Treatment Sales Volume (2016-2021)
3.11.1 South America Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.11.2 South America Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Psoriasis Treatment Sales Volume (2016-2021)
3.12.1 Rest of the World Psoriasis Treatment Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Psoriasis Treatment Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Psoriasis Treatment Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Psoriasis Treatment Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Psoriasis Treatment Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Psoriasis Treatment Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Psoriasis Treatment Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Psoriasis Treatment Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Psoriasis Treatment Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Psoriasis Treatment Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Psoriasis Treatment Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Psoriasis Treatment Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Psoriasis Treatment Sales Volume Market Share by Type (2016-2021)
14.2 Global Psoriasis Treatment Sales Revenue Market Share by Type (2016-2021)
14.3 Global Psoriasis Treatment Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Psoriasis Treatment Consumption Volume by Application (2016-2021)
15.2 Global Psoriasis Treatment Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Psoriasis Treatment Business
16.1 Novartis International AG
16.1.1 Novartis International AG Company Profile
16.1.2 Novartis International AG Psoriasis Treatment Product Specification
16.1.3 Novartis International AG Psoriasis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Johnson & Johnson
16.2.1 Johnson & Johnson Company Profile
16.2.2 Johnson & Johnson Psoriasis Treatment Product Specification
16.2.3 Johnson & Johnson Psoriasis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Pfizer Inc.
16.3.1 Pfizer Inc. Company Profile
16.3.2 Pfizer Inc. Psoriasis Treatment Product Specification
16.3.3 Pfizer Inc. Psoriasis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Merck and Co. Inc.
16.4.1 Merck and Co. Inc. Company Profile
16.4.2 Merck and Co. Inc. Psoriasis Treatment Product Specification
16.4.3 Merck and Co. Inc. Psoriasis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 AbbVie and Amgen
16.5.1 AbbVie and Amgen Company Profile
16.5.2 AbbVie and Amgen Psoriasis Treatment Product Specification
16.5.3 AbbVie and Amgen Psoriasis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Eli Lilly
16.6.1 Eli Lilly Company Profile
16.6.2 Eli Lilly Psoriasis Treatment Product Specification
16.6.3 Eli Lilly Psoriasis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Psoriasis Treatment Manufacturing Cost Analysis
17.1 Psoriasis Treatment Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Psoriasis Treatment
17.4 Psoriasis Treatment Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Psoriasis Treatment Distributors List
18.3 Psoriasis Treatment Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Psoriasis Treatment (2022-2027)
20.2 Global Forecasted Revenue of Psoriasis Treatment (2022-2027)
20.3 Global Forecasted Price of Psoriasis Treatment (2016-2027)
20.4 Global Forecasted Production of Psoriasis Treatment by Region (2022-2027)
20.4.1 North America Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.4.3 Europe Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.4.7 Africa Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.4.9 South America Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Psoriasis Treatment Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Psoriasis Treatment by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Psoriasis Treatment by Country
21.2 East Asia Market Forecasted Consumption of Psoriasis Treatment by Country
21.3 Europe Market Forecasted Consumption of Psoriasis Treatment by Countriy
21.4 South Asia Forecasted Consumption of Psoriasis Treatment by Country
21.5 Southeast Asia Forecasted Consumption of Psoriasis Treatment by Country
21.6 Middle East Forecasted Consumption of Psoriasis Treatment by Country
21.7 Africa Forecasted Consumption of Psoriasis Treatment by Country
21.8 Oceania Forecasted Consumption of Psoriasis Treatment by Country
21.9 South America Forecasted Consumption of Psoriasis Treatment by Country
21.10 Rest of the world Forecasted Consumption of Psoriasis Treatment by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
